FDA Inspection
HP Halden Pharma ASHP Halden Pharma AS – FDA Inspection, May 26, 2017
Record Details
This FDA Inspection record concerns HP Halden Pharma AS, with an inspection on May 26, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7c786982-397a-49f8-8510-c4470f6f5a87
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1014636
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of HP Halden Pharma AS
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 3, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for HP Halden Pharma AS
- FDA Inspection 1205610 - 2023-05-10
- FDA Inspection 1101303 - 2019-09-03
- FDA Inspection 931958 - 2015-06-26
- FDA Inspection 863615 - 2013-12-20
- FDA Inspection 797565 - 2012-08-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.